Cargando…
The introduction of mutations in the wild type coxsackievirus B3 (CVB3) IRES RNA leads to different levels of in vitro reduced replicative and translation efficiencies
Coxsackievirus B3 (CVB3) is a principal causative agent of viral myocarditis, meningitis and pancreatitis. There is no vaccine available for clinical use. It has been demonstrated that the primary molecular determinant of virulence phenotype is located in the 5’ UTR of the viral genome. Translation...
Autores principales: | Gharbi, Jawhar, Almalki, Mohammed A., Ben M’hadheb, Manel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529112/ https://www.ncbi.nlm.nih.gov/pubmed/36190999 http://dx.doi.org/10.1371/journal.pone.0274162 |
Ejemplares similares
-
Impaired binding of standard initiation factors eIF3b, eIF4G and eIF4B to domain V of the live-attenuated coxsackievirus B3 Sabin3-like IRES - alternatives for 5′UTR-related cardiovirulence mechanisms
por: Souii, Amira, et al.
Publicado: (2013) -
Molecular Analysis of RNA-RNA Interactions between 5′ and 3′ Untranslated Regions during the Initiation of Translation of a Cardiovirulent and a Live-Attenuated Coxsackievirus B3 Strains
por: Souii, Amira, et al.
Publicado: (2013) -
Ribosomal Initiation Complex Assembly within the Wild-Strain of Coxsackievirus B3 and Live-Attenuated Sabin3-like IRESes during the Initiation of Translation
por: Souii, Amira, et al.
Publicado: (2013) -
Cloning and Molecular Characterization of the Recombinant CVB4E2 Immunogenic Viral Protein (rVP1), as a Potential Subunit Protein for Vaccine and Immunodiagnostic Reagent Candidate
por: Hadj Hassine, Ikbel, et al.
Publicado: (2023) -
Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains in Mice Model
por: Gharbi, Jawhar, et al.
Publicado: (2023)